Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-14

Clinical Trial Update: A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil [Phase 4]

View source ↗

Summary

A Phase 4 pragmatic study evaluating the efficacy and safety of mepolizumab for severe uncontrolled asthma in Brazil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mepolizumab (mepolizumab)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Eosinophilic Asthma | Phase 4 | Status: UNKNOWN